The UK Intellectual Property Office ("IPO") is currently suspending all inter partes proceedings involving International Registrations ("IRs") designating the UK where no UK-based address...

The Unified Patent Court (UPC) Court of Appeal has issued a significant decision in Fujifilm v Kodak (UPC_CoA_699/2025)...

Under the terms of the draft agreement, a transition term will be implemented up until 31 December 2020.

To what extent will a Supplementary Protection Certificate for a biological product be considered to encompass closely-related alternatives such as biosimilars.

Technical Board of Appeal 3.5.07 has now applied the opinion given by the Enlarged Board of Appeal in G 1/19 (discussed in our Briefing here) to the pedestrian simulation application where the referral was made.

A BBC News article has highlighted a recent increase in the use of well-known restaurant names in fraudulent company registrations at Companies House.

Four pending cases before the Court of Justice of the European Union are set to clarify critical aspects of Supplementary Protection Certificate (SPC) law, addressing questions about manufacturing waivers, the definition of medicinal products, and what constitutes a "first" marketing authorisation. These referrals from Danish, German, and Czech courts involve major pharmaceutical companies and could significantly impact SPC strategy across EU member states.

Ion channels are pore-forming protein complexes that allow for the transport of charged ‘ions' across the cell membrane. The flow of ions through these channels results in the production of an electrical signal.

The new version of the EPO's Guidelines for Examination is due to come into force on 1 March 2021. In advance of the Guidelines entering into force, the EPO has now published a draft version of the Guidelines here.

Chocolate has been consumed as a drink in the UK since as early as 1600, according to the British Museum. As a result, it is perhaps unsurprising that one of the oldest trade mark registrations...

In order to benefit from the Patent Box, a company must hold or have an exclusive license to a qualifying IP right. Here we discuss the definition of a qualifying IP right.

The Board of Appeal in case T0318/14 has indicated in the minutes of oral proceedings held on 7 February 2019 that the following questions concerning double patenting are being referred

In the 2016 decision T 2440/12-Fluid flow simulation/SIMCON, Technical Board of Appeal 3.5.07 has found that a commercially available software package makes...

In semiconductor technology, the term "node" is used to refer to the size of the smallest feature of a transistor.

Premature mortality from preventable causes, including maternal and infant deaths, remains a significant global health issue. In this Insight, we explore how advances in plant biotechnology can assist with meeting United Nations Sustainable Development Goal Number 3: "Ensure healthy lives and promote well-being for all at all ages"

The Enlarged Board of Appeal (EBA) has issued its highly anticipated decision in case G1/24. The case concerns the extent to which the description and figures should be referred to when interpreting the claims for assessing patentability.

The regulatory exclusivity periods exist to compensate marketing authorisation holders for the investment required to carry out the necessary pre-clinical and clinical studies to achieve authorisation for a new product.

As we recently reported, the Board of Appeal in T697/22 has referred questions to the EBA concerning whether the description should be amended to address any inconsistencies with the claims.

The Enlarged Board of Appeal (EBA) has issued its preliminary opinion in case G 1/25. The case concerns whether the description of a European patent application should be amended to address any inconsistencies with the claims.

A recent Italian court decision challenges the widely accepted interpretation of the UPC transitional period, potentially requiring patent holders to file opt-outs before bringing actions in national courts. The Court of Venice ruled that non-opted-out European patents fall under exclusive UPC jurisdiction, contradicting the prevailing view that parallel jurisdiction exists during the transitional period.